Biden Administration Action to Increase Section 301 China Tariffs – The Details
This article includes details of products, rate increases, timelines, and the background behind the Biden Administration’s Section 301 Tariff Increase Proposal.
The Case for More Aggressive Tariffs, Exchange Rates, and Monetary Policy
The next president should use every tool to rebuild America’s productivity, industrial base and middle class. And they should ignore the conventional economic textbook view that predicts calamity if those tools are used, especially because these predictions never come true.
Senate Finance’s Subcommittee on Trade Takes One-Sided Approach to De Minimis Import Rule
The U.S. Senate Finance Subcommittee for International Trade, Customs, and Global Competitiveness took a one-sided view on the de minimis exemption in a hearing on Tuesday, rejecting anything but technocratic changes to the global duty-free rule for small packages priced under $800.
A New Trade Policy Has Emerged: CPA CEO Michael Stumo Chats with USTR Senior Advisor Beth Baltzan
A new trade policy isn’t just emerging; it’s emerged. Six years after former President Donald Trump and his chief trade diplomat Robert Lighthizer imposed tariffs on nearly $400 billion worth of imported goods from China, President Biden has done the same.
CPA Welcomes DHS Adding 26 Chinese Textile Companies to UFLPA Entity List
We welcome the recent action by DHS to place 26 more Chinese textile companies on the UFLPA Entity List. However, more needs to be done to ensure that Chinese forced labor imports are not skirting the enforcement of U.S. law.
Members of Coalition To Close The De Minimis Loophole Provide Evidence Demonstrating the Significant Role De Minimis Plays in Illicit Fentanyl Trafficking
WASHINGTON, D.C. — Members of the Coalition to Close the De Minimis Loophole, representing diverse American voices and millions of people committed to fix the
Veterans Hospitals Ban Use of China-Made Syringes Due to Safety Issues
The Veterans Health Administration (VHA) banned the use of plastic syringes made in China on April 23 due to safety concerns, ahead of a warning letter dated April 24 to Ohio-based importer Cardinal Health by the Food and Drug Administration.
Goods Deficit Flat at $91.4 Billion in February, As Mexico Takes Over China’s Position as Top Source of Imports
While the month-over-month goods deficit with China fell by around $3.7 billion, the deficit with Mexico rose by $2 billion over the same period.
America’s Life-Threatening Drug Shortages Reach Record Highs
Despite spending over $600 billion on prescription drugs, the number of drugs in shortage rose to a near-record total of 301 active medication shortages at the end of 2023.
Mexico Is Growing as New China Hub; 2024 Exports Already Breaking Records
Mexico is fast becoming a new hub for China offshore investment and exports.
